NCI Awards $9M to OSU-IU Center for Cancer Systems Biology for Epigenetic Research

Over the next five years, researchers from Ohio State University and Indiana University will study epigenetic changes in prostate, breast, and ovarian cancer cells that cause resistance to hormonal therapy or traditional chemotherapy.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories